Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Amortizatization of Intangibles: 2018-2024

Historic Amortizatization of Intangibles for Arcus Biosciences (RCUS) over the last 7 years, with Dec 2024 value amounting to $25.0 million.

  • Arcus Biosciences' Amortizatization of Intangibles fell 50.00% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year decrease of 36.00%. This contributed to the annual value of $25.0 million for FY2024, which is 31.58% up from last year.
  • According to the latest figures from FY2024, Arcus Biosciences' Amortizatization of Intangibles is $25.0 million, which was up 31.58% from $19.0 million recorded in FY2023.
  • Arcus Biosciences' 5-year Amortizatization of Intangibles high stood at $25.0 million for FY2024, and its period low was -$5.0 million during FY2021.
  • For the 3-year period, Arcus Biosciences' Amortizatization of Intangibles averaged around $17.3 million, with its median value being $19.0 million (2023).
  • Per our database at Business Quant, Arcus Biosciences' Amortizatization of Intangibles slumped by 600.00% in 2021 and then soared by 260.00% in 2022.
  • Yearly analysis of 5 years shows Arcus Biosciences' Amortizatization of Intangibles stood at $1.0 million in 2020, then slumped by 600.00% to -$5.0 million in 2021, then skyrocketed by 260.00% to $8.0 million in 2022, then soared by 137.50% to $19.0 million in 2023, then soared by 31.58% to $25.0 million in 2024.